Point72 Asset Management
BIOR

Point72 Asset Management’s Biora Therapeutics, Inc. Common Stock BIOR Stock Holding History

Point72 Asset Management’s Portfolio BIOR Stock Details BIOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-898
Closed -$1.19M – 1254
2020
Q4 		$1.19M Buy
+898
New +$1.32M 0.01% 790
2020
Q3 		– Sell
-200
Closed -$450K – 1152
2020
Q2 		$450K Buy
+200
New +$545K ﹤0.01% 718

Other funds holding BIOR

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Point72 Asset Management's BIOR Position: Q1 2021 in Review

Point72 Asset Management sold out of Biora Therapeutics, Inc. Common Stock (BIOR) in Q1 2021, closing a stake of 898 shares — an estimated $1.19M sold.

Point72 Asset Management first reported a position in BIOR in Q2 2020 and held it in 2 quarters. The position peaked at $1.19M in Q4 2020. 47 funds tracked by Wall St. Rank hold BIOR as of Q1 2021.

  • Point72 Asset Management reported no remaining Biora Therapeutics, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Point72 Asset Management sold 898 Biora Therapeutics, Inc. Common Stock shares in Q1 2021, an estimated $1.19M.
  • Point72 Asset Management first reported a position in Biora Therapeutics, Inc. Common Stock in Q2 2020 and held it in 2 quarters.
  • Point72 Asset Management's Biora Therapeutics, Inc. Common Stock position peaked at $1.19M in Q4 2020.
  • 47 funds tracked by Wall St. Rank held Biora Therapeutics, Inc. Common Stock as of Q1 2021.

Based on Point72 Asset Management's 13F filing for Q1 2021, filed 17 May 2021.